Stock listing

NASDAQ:EPZM Epizyme Inc Stock

Follow Epizyme Inc into a list and get an email when it puts out news.

Last close · NASDAQ:EPZM

$1.47 USD

Close on Aug 12, 2022 · No longer trades

May 31, 2013 to last close -93.6% · weekly closes, May 31, 2013 – Aug 12, 2022
Lowest – highest close
$0.415 – $43.60 USDSince May 31, 2013 · lowest Jun 1, 2022 · highest Jul 16, 2013

Delisted NASDAQ:EPZM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:EPZM
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Epizyme Inc on 6ix

Calls
6 calls with a replay · 6 with a transcript · latest May 10, 2022
Decks
3 decks · latest Jan 4, 2019

Events

CallWhenStatus
Epizyme (EPZM) Q1 2022 Earnings CallTue, May 10, 2022 · 8:30 AM ETReplay
Epizyme (EPZM) Q4 2021 Earnings CallTue, Mar 01, 2022 · 8:30 AM ETReplay
Epizyme (EPZM) Q3 2021 Earnings CallTue, Nov 09, 2021 · 8:30 AM ETReplay
Epizyme (EPZM) Q2 2021 Earnings CallMon, Aug 09, 2021 · 8:30 AM ETReplay
Epizyme (EPZM) Q1 2021 Earnings CallThu, May 06, 2021 · 7:30 AM ETReplay
Epizyme (EPZM) Q4 2020 Earnings CallTue, Feb 23, 2021 · 8:00 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (January 2019)Investor deck31 slidesJan 4, 2019
J.P. Morgan 2018 Healthcare ConferenceConference26 slidesJan 8, 2018
J.P. Morgan 2017 Healthcare ConferenceConference31 slidesJan 9, 2017

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Beth C Seidenberg
Other companies: Latigo Biotherapeutics, Inc. (Director · Since at least Aug 6, 2026); Kyverna Therapeutics, Inc. (Director · Since at least Feb 7, 2024); Sagimet Biosciences Inc. - Series A (Director · Since at least Jul 13, 2023); Vera Therapeutics, Inc. (Director · Since at least May 13, 2021); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Progyny, Inc. (Director · Oct 24, 2019 – May 23, 2024 · Past); Armo Biosciences Inc. (Director · Jan 25, 2018 – Jun 22, 2018 · Past); Atara Biotherapeutics, Inc. (Director · Oct 15, 2014 – May 31, 2023 · Past); Tesaro Inc (Director · Jun 27, 2012 – Jan 22, 2019 · Past)
Director · May 30, 2013 – Jun 30, 2019 · Past
Kevin T Conroy
Other companies: Abbott Laboratories (Director · Since at least Apr 24, 2026); American Exceptionalism Acquisition Corp. A (Director · Since at least Sep 25, 2025); Align Technology, Inc. (Director · Since at least Dec 5, 2023); EXACT Sciences Corporation (President and CEO, Director · Since at least Mar 18, 2009); Adaptive Biotechnologies Corporation (Director · Jun 26, 2019 – Mar 6, 2023 · Past); ARYA Sciences Acquisition Corp (Director · Oct 5, 2018 – Jul 1, 2020 · Past)
Director · Feb 6, 2017 – Aug 12, 2022 · Past
Thomas Daniel
Other companies: Gossamer Bio, Inc. (Director · Since at least Feb 7, 2019); Dianthus Therapeutics, Inc. (Director · Jun 20, 2018 – Jun 28, 2022 · Past); Larimar Therapeutics, Inc. (Director · Mar 3, 2016 – May 12, 2021 · Past); Juno Therapeutics Inc (Director · Aug 11, 2015 – Mar 5, 2018 · Past); Celgene Corporation (see remarks · Feb 15, 2012 – Dec 31, 2015 · Past)
Director · May 30, 2013 – May 30, 2013 · Past
Jason Rhodes
Other companies: Dyne Therapeutics, Inc. (Chairman · Since at least Sep 16, 2020); Generation Bio Co (Director · Since at least Jun 11, 2020); Disc Medicine, Inc. (Director · Feb 5, 2021 – Oct 4, 2021 · Past); Replimune Group, Inc. (Director · Jul 19, 2018 – Apr 1, 2022 · Past)
President, CFO and Treasurer · May 30, 2013 – Sep 22, 2014 · Past
Richard F. Pops
Other companies: Alkermes plc (Director · Since at least Sep 10, 2015); Neurocrine Biosciences, Inc. (Director · Since at least May 28, 2015); Acceleron Pharma Inc (Director · Mar 3, 2016 – Jan 25, 2019 · Past)
Director · Jul 8, 2015 – May 29, 2020 · Past
Grant Bogle
Other companies: Nuvalent, Inc. (Director · Since at least Dec 5, 2024); Tesaro Inc (Sr. VP, Chief Commercial Ofc · Jul 13, 2015 – Jan 22, 2019 · Past)
President and CEO, Director · Sep 2, 2019 – Aug 12, 2022 · Past
Matthew Ros
Other companies: Cogent Biosciences, Inc. (Pharma-Biotech Executive · Since at least Jul 26, 2019); Verastem, Inc. (Chief Operating Officer · Jan 14, 2025 – Nov 4, 2026 · Past)
See Remarks · May 16, 2016 – Aug 16, 2021 · Past
Shefali Agarwal
Other companies: Fate Therapeutics, Inc. (Board Member · Since at least Jul 15, 2019); Gritstone bio, Inc. (Director · Jun 1, 2021 – Apr 4, 2025 · Past)
See Remarks · Jul 23, 2018 – Mar 17, 2022 · Past
Susan E. Graf
Other companies: Aardvark Therapeutics, Inc. (Board Member · Since at least Feb 12, 2025); CG Oncology, Inc. (Director · Since at least Jan 24, 2024)
Chief Business Officer · Apr 25, 2016 – Feb 9, 2018 · Past
Victoria Vakiener
Other companies: Arrowhead Pharmaceuticals, Inc. (Director · Since at least May 2, 2022); Chimerix Inc (Director · Apr 22, 2021 – Apr 21, 2025 · Past)
Chief Commercial Officer · Sep 18, 2020 – Feb 4, 2021 · Past
All 16 people
PersonSeat
Carol Stuckley
Other companies: Centessa Pharmaceuticals PLC (Director · Since at least May 27, 2021)
Director · Nov 16, 2021 – Aug 12, 2022 · Past
Joseph Beaulieu
Other companies: Disc Medicine, Inc. (SVP, Finance · Since at least Nov 5, 2026)
See Remarks · Aug 9, 2022 – Aug 12, 2022 · Past
Michael F Giordano
Other companies: RAPT Therapeutics Inc (Director · Since at least May 28, 2021)
Director · Jun 11, 2021 – Aug 12, 2022 · Past
Roy A Beveridge
Other companies: Humana Inc. (Chief Medical Officer · Jun 17, 2013 – Apr 1, 2019 · Past)
Director · Nov 16, 2021 – Aug 12, 2022 · Past
Andrew E SingerEVP & CFO · Feb 8, 2016 – Aug 9, 2017 · Past
Suzanne FlemingSVP · Sep 20, 2017 – Feb 9, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about Epizyme Inc.